We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $43.3B
1-Year Est. Return 29.3%
This Fund
S&P 500
This Quarter Est. Return
+17.09%
1 Year Est. Return
+29.3%
3 Year Est. Return
+83.12%
5 Year Est. Return
+90.93%
10 Year Est. Return
+282.52%
AUM
$43.3B
AUM Growth
+$4.47B
Cap. Flow
-$120M
Cap. Flow %
-0.28%
Top 10 Hldgs %
19.72%
Holding
4,210
New
286
Increased
1,913
Reduced
1,499
Closed
436

Sector Composition

Rank Sector Weight
1 Technology 13.13%
2 Financials 4.34%
3 Industrials 3.63%
4 Consumer Discretionary 3.11%
5 Communication Services 2.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TALKW
4076
DELISTED
Talkspace Inc Warrant
TALKW
-10,550
Closed
TBUX icon
4077
T. Rowe Price Ultra Short-Term Bond ETF
TBUX
$1.29B
-223,533
Closed -$11.1M
TCHP icon
4078
T. Rowe Price Blue Chip Growth ETF
TCHP
$2.07B
-89,245
Closed -$3.94M
TDVG icon
4079
T. Rowe Price Dividend Growth ETF
TDVG
$1.42B
-76,479
Closed -$3.41M
TEAM icon
4080
Atlassian
TEAM
$24.3B
-3,151
Closed -$215K
TEQI icon
4081
T. Rowe Price Equity Income ETF
TEQI
$444M
-32,915
Closed -$1.48M
TFLR icon
4082
T. Rowe Price Floating Rate ETF
TFLR
$673M
-78,931
Closed -$3.98M
TGRT icon
4083
T. Rowe Price Growth ETF
TGRT
$1.46B
-53,532
Closed -$2.1M
TLSI icon
4084
TriSalus Life Sciences
TLSI
$265M
-15,554
Closed -$62K
TMSL icon
4085
T. Rowe Price Small-Mid Cap ETF
TMSL
$2.74B
-363,826
Closed -$13.3M
TOKE
4086
DELISTED
Cambria Cannabis ETF
TOKE
-12,319
Closed -$63K
TOUS icon
4087
T. Rowe Price International Equity ETF
TOUS
$1.56B
-103,292
Closed -$3.57M
TRX icon
4088
TRX Gold Corp
TRX
$263M
-10,982
Closed -$16K
TSPA icon
4089
T. Rowe Price US Equity Research ETF
TSPA
$4.17B
-352,976
Closed -$14.4M
TVAL icon
4090
T. Rowe Price Value ETF
TVAL
$986M
-63,072
Closed -$2.28M
TWM icon
4091
ProShares UltraShort Russell2000
TWM
$43.7M
-19,195
Closed -$594K
UCO icon
4092
ProShares Ultra Bloomberg Crude Oil
UCO
$414M
-13,054
Closed -$513K
UCON icon
4093
First Trust Smith Unconstrained Bond ETF
UCON
$3.27B
-997,473
Closed -$24.7M
UHS icon
4094
Universal Health Services
UHS
$9.64B
-1,408
Closed -$252K
UI icon
4095
Ubiquiti
UI
$32.7B
-339
Closed -$268K
UTI icon
4096
Universal Technical Institute
UTI
$2.12B
-10,788
Closed -$389K
VC icon
4097
Visteon
VC
$2.82B
-3,153
Closed -$287K
VIOO icon
4098
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.15B
-137,808
Closed -$15.8M
VIOV icon
4099
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.85B
-61,179
Closed -$6.22M
VONG icon
4100
Vanguard Russell 1000 Growth ETF
VONG
$42.3B
-221,330
Closed -$24.3M

Similar funds

Cambridge Investment Research Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Cambridge Investment Research Advisors held 4,210 positions worth $43.3B, up 12% from $38.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q2 2026 filing shows 286 new, 1,913 increased, 1,499 reduced and 436 closed positions. Its largest new stake was SpaceX: 259,405 shares worth $44.3M. The largest sale was FT Vest Fund of Buffer ETFs, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Cambridge Investment Research Advisors's largest Q2 2026 buy was SpaceX: 259,405 shares worth $44.3M.
  • Cambridge Investment Research Advisors added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2026, an estimated $126M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2026 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $73.5M.
  • Cambridge Investment Research Advisors fully exited FT Vest Fund of Buffer ETFs in Q2 2026, selling an estimated $111M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $43.3B portfolio in Q2 2026.
  • Cambridge Investment Research Advisors opened 286 new positions and closed 436 in Q2 2026.
  • Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $43.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.